Tuyl Christopher Van
General Counsel at Immunovant, Inc. (IMVT)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $1.5M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Oct 9 NewSEC | IMVTImmunovant, Inc. | Sell | 1,327175,218 held (−1%) | $32.06 | $43K | -5.0% |
| Sep 25SEC | IMVTImmunovant, Inc. | Sell | 2,846176,545 held (−2%) | $36.36 | $103K | -16.2% |
| Jul 10SEC | IMVTImmunovant, Inc. | Sell | 1,143179,454 held (−1%) | $39.53 | $45K | -22.9% |
| Jul 10SEC | IMVTImmunovant, Inc. | Sell | 63179,391 held (−0%) | $39.99 | $3K | -23.8% |
| Jun 26SEC | IMVTImmunovant, Inc. | Sell | 14,982183,439 held (−8%) | $38.19 | $572K | -20.2% |
| Jun 26SEC | IMVTImmunovant, Inc. | Sell | 2,842180,597 held (−2%) | $38.96 | $111K | -21.8% |
| Jun 22SEC | IMVTImmunovant, Inc. | Sell | 2,634180,597 held (−1%) | $35.39 | $93K | -13.9% |
| Apr 10SEC | IMVTImmunovant, Inc. | Sell | 5,165183,231 held (−3%) | $24.83 | $128K | +22.7% |
| Mar 20SEC | IMVTImmunovant, Inc. | Sell | 2,877147,053 held (−2%) | $24.97 | $72K | +22.0% |
| Dec 19SEC | IMVTImmunovant, Inc. | Sell | 8,529152,214 held (−5%) | $26.78 | $228K | +13.8% |
| Dec 19SEC | IMVTImmunovant, Inc. | Sell | 2,284149,930 held (−2%) | $27.38 | $63K | +11.3% |